In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anamorelin is a drug that mimics the function of ghrelin in the human body, whic···【more】
Release date:2024-08-22Recommended:245
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a ···【more】
Release date:2024-08-22Recommended:295
Koselugo is a class of finely designed small molecule MEK blockers (also known a···【more】
Release date:2024-08-22Recommended:291
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic···【more】
Release date:2024-08-22Recommended:306
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as···【more】
Release date:2024-08-22Recommended:260
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that i···【more】
Release date:2024-08-22Recommended:266
Anamorelin is a drug for cancer cachexia that increases a patient's appetite···【more】
Release date:2024-08-21Recommended:329
As a selective ghrelin receptor agonist, anamolin is approved in Japan for impro···【more】
Release date:2024-08-21Recommended:249
Through its unique pharmacological effects, Anamoreline is effective in helping ···【more】
Release date:2024-08-21Recommended:234
Anamorelin helps cancer patients with dyscrasia restore the body's energy su···【more】
Release date:2024-08-21Recommended:282
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by vario···【more】
Release date:2024-08-21Recommended:308
Anamorelin is a novel ghrelin receptor agonist specifically designed for the tre···【more】
Release date:2024-08-21Recommended:377